In this section of the Lung Therapeutics Online Press Kit, you'll find our news releases. The releases are listed in chronological order and are archived by month and year.
-
Jun 6, 2017
Financing will support further development of the Company’s LTI-03 transformative drug technology and the current multi-site clinical trial of orphan drug LTI-01.
-
Mar 14, 2017
LTI-01 addresses unmet needs in a $600+ million global market. Intended to replace costly surgery and ineffective off-label treatments of fibrosis, the drug can provide safer and more cost-effective therapeutic options for CPE/empyema patients and healthcare providers worldwide.
-
-
